The future of the global nucleic acid testing market looks promising with opportunities in the hospital & clinic, pathology laboratory, and academic & research organization markets. The global nucleic acid testing market is expected to reach an estimated $6.7 billion by 2030 with a CAGR of 11.2% from 2024 to 2030. The major drivers for this market are rising need for precise and quick diagnostic tests, increasing need for nucleic acid test kits from blood banks and transfusion centers, and escalating incidence of cancer, genetic disorders, and infectious diseases.
Some of the key questions
answered in this exclusive report are:
Q.1. What are some of
the most promising, high-growth opportunities for the nucleic acid testing
market by product type (polymerase chain reaction, ligase chain reaction,
transcription–mediated amplification, whole genome sequencing, and others),
indication (infectious disease, cancer, forensic testing, personalized
medicine, and others), end use (hospitals & clinics, pathology
laboratories, academic & research organization, and others), and region
(North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will
grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and
why?
Q.4. What are the key
factors affecting market dynamics? What are the key challenges and business
risks in this market?
Q.5. What are the
business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market
and the reasons behind them?
Q.7. What are some of
the changing demands of customers in the market?
Q.8. What are the new
developments in the market? Which companies are leading these developments?
Q.9. Who are the major
players in this market? What strategic initiatives are key players pursuing for
business growth?
Q.10. What are some of
the competing products in this market and how big of a threat do they pose for
loss of market share by material or product substitution?
Q.11. What M&A
activity has occurred in the last 5 years and what has its impact been on the
industry?
Market Segmentation:
In this market,
infectious disease, cancer, forensic testing, and personalized medicine are the
major segments of nucleic acid testing market by indication. Lucintel forecasts
that infectious disease will remain the largest segment due to considerable use
of nucleic acid testing kit for genotype and subtype identification that aids
in determining viral load.
Within this market, hospital & clinic is expected to witness highest growth over the forecast period.
North America is
expected to witness highest growth over the forecast period due to increasing
prevalence of infectious diseases among population and presence of strong
government support for nucleic acid testing research and development in the
region.
F. Hoffmann-La Roche,
Becton and Dickinson, Danaher, Abbott Laboratories, Illumina, Siemens
Healthineers, and bioMérieux are the major suppliers in the nucleic acid
testing market.
About
Lucintel
Lucintel, the premier global
management consulting and market research firm, creates winning strategies for
growth. It offers market assessments, competitive analysis, opportunity
analysis, growth
consulting, M&A, and due diligence services to executives and
key decision-makers in a variety of industries.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Related Reports
1. Pharmaceutical Contract Manufacturing Market
3. Stent Market
5. 3D
Printing Medical Device Market
8. Medical Lifting Sling
Market
10. Stretcher Market
No comments:
Post a Comment